First, the companies represented in the Series B and C line are a mix of companies that Redpoint would “want to look at,” according to Logan Bartlett, a managing director at the venture firm.

Source: https://techcrunch.com/2023/04/04/whats-a-fair-price-premium-for-startup-shares/

Nearly a year ago, Rivus Pharmaceuticals unveiled a $132 million Series B round of financing to support mid-stage clinical development of drugs it calls controlled metabolic accelerators.

Source: https://medcitynews.com/2023/08/still-hungry-for-new-obesity-meds-novo-nordisk-makes-another-ma-deal/

They include France’s Mistral AI, which in the continent’s largest-ever seed round, and Aleph Alpha, which this month secured €460m in Series B funding.

Source: https://thenextweb.com/news/european-ai-supporting-tech-sector-recovery

This is more than evident with France’s Mistral, the generative AI startup that raised €105 million just one month after founding (and last week raised a further €385 million), and Germany’s Aleph Alpha bagging €500 million in its Series B round.

Source: https://thenextweb.com/news/european-tech-2024-optimism

This Series B funding takes Hack The Box’s total amount of capital raised to date to $70 million, fortifying the company’s position within the global cybersecurity ecosystem.

Source: https://www.helpnetsecurity.com/2023/01/11/hack-the-box-investment/

While the firm is still focused on seed and early-stage funding for promising startups, the Opportunity Fund will seek to back follow-on investments for portfolio companies that are raising Series A and Series B rounds.

Source: https://www.timesofisrael.com/israels-cyberstarts-closes-480m-fund-for-cybersecurity-investments/